1. Combined xCT and mTOR Inhibition as a New Therapeutic Option for Pancreatic Adenocarcinoma. (2022) Authors: Newcomer, K.; Spitzer, D.; Ross, L.; Caldwell, K.; Vangveravong, S.; Van Tine, B.; Hawkins, W. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗